Recall
FDAHealthOctober 24, 2025

Cipla USA, Inc. — Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for :

⚠️ Failed stability specifications: Out of specification for hardness test

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
October 24, 2025

Nationwide in the USA

What's affected?

Product
Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-936-98.
UPC
0369097935894
Lot code
NB240315

Additional details

lot# NB240315, exp 12/31/2025

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 1180 boxes.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.